The device earned FDA clearance and breakthrough designation earlier in 2024, and it features a pelvis-specific design to improve fixation and reduce the risk of screw backout. It is designed to address anatomic and biomechanical challenges of pelvic fractures, especially in patients with poor bone quality.
Edward Westrick, MD, of Pittsburgh-based Allegheny General Hospital; Reza Firoozabadi, MD, of Seattle-based Harborview Medical Center; J.D. Black, MD, of Richland, Wash.-based Kadlec Regional Medical Center, and Brian Cunningham, MD, of St. Louis Park, Minn.-based Methodist Hospital – HealthPartners were among the first surgeons to use the device.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
